Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,387,462
+$2,969,052 QoQ
Shares Held
92,656
-20.9% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#70
of 334 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAXTON ASSOCIATES LLP holds $23,868,011 across 6 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (31.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
112,856 | $8,109,832 | |
| 2 | LQDA |
Liquidia Corp
This page
|
92,656 | $7,387,462 | |
| 3 | VTRS |
Viatris Inc
|
255,423 | $4,056,117 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
21,854 | $2,424,482 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
56,917 | $1,443,984 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
9,438 | $446,134 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,387,462 | 92,656 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,418,410 | 117,075 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,346,156 | 155,006 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $389,331 | 17,121 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||